MEDASENSE LAUNCHES NEW PAIN MONITORING DEVICE, PMD-200™ FOLLOWING EUROPEAN CE APPROVAL

PMD-200 Launch: New state-of-the-art technology helps clinicians provide personalised pain management Ramat Gan, Israel, 18 January 2017 — Medasense Biometrics Ltd. announced today that it has received CE mark approval…

Continue ReadingMEDASENSE LAUNCHES NEW PAIN MONITORING DEVICE, PMD-200™ FOLLOWING EUROPEAN CE APPROVAL

Medasense Biometrics Ltd. Raises $8 Million Investment in Series B Financing

Medasense Biometrics Ltd. Raises $8 Million Investment in Series B Financing Accelerating the Commercialization of Objective Pain Monitoring  Medasense Biometrics Ltd., developer of a proprietary objective pain monitoring technology, announced…

Continue ReadingMedasense Biometrics Ltd. Raises $8 Million Investment in Series B Financing